New Side Effects in Prolonged Chlorpromazine Therapy

1965 ◽  
Vol 10 (2) ◽  
pp. 109-111 ◽  
Author(s):  
Anthony C. Greiner ◽  
George A. Nicolson

Three new side effects of prolonged chlorpromazine therapy have been described. Their pathogenesis has been discussed, and increased melanin production was found to be the cause of these manifestations of chlorpromazine melanosis. Skin pigmentation has produced an appearance which is cosmetically undesirable. Ocular deposits have caused visual impairment. Diffuse melanosis of internal organs has been accompanied by functional disturbance of the involved organs. A preliminary report on the therapy of these side effects has been presented.

2016 ◽  
Vol 9 (4) ◽  
pp. 724-729 ◽  
Author(s):  
Magdalena Wrzesińska ◽  
Klaudia Tabała ◽  
Patryk Stecz

2018 ◽  
Vol 62 (3) ◽  
pp. 329-333 ◽  
Author(s):  
Anna Snarska ◽  
Dominika Wysocka ◽  
Liliana Rytel ◽  
Sławomir Gonkowski ◽  
Hanna Pawelec ◽  
...  

AbstractIntroductionSimvastatin is a substance which is commonly used as a medicine to reduce cholesterol level. Unfortunately, it shows numerous side effects. Simvastatin affects various internal organs, and among other detriments to health may cause persistent muscle weakness, osteolytic processes, headaches, and rashes. Until now knowledge of the influence of simvastatin on bone marrow cells has been rather scant and fragmentary.Material and MethodsDuring this experiment the numbers of all types of cells in the leukocytic system of porcine bone marrow were evaluated after 28 and 56 days of oral administration of simvastatin at a dose of 40 mg/day/animal.ResultsSimvastatin caused an increase in the number of all types of cells in the leukocytic system, and the most visible fluctuations concerned promyelocytes.ConclusionObservations obtained during the present study indicated that the results of the action of simvastatin on porcine bone marrow differ from those observed in other mammal species, including human. This may be due to various metabolic pathways within the bone marrow in the particular species, but the exact mechanisms of these actions are unknown at the present time.


2019 ◽  
Vol 20 (4) ◽  
pp. 8-18
Author(s):  
Hunter J. Bennett ◽  
Kevin A. Valenzuela ◽  
Kristina Fleenor ◽  
Steven Morrison ◽  
Justin A. Haegele

2018 ◽  
Vol 11 (555) ◽  
pp. eaau7987 ◽  
Author(s):  
Dalee Zhou ◽  
Koji Ota ◽  
Charlee Nardin ◽  
Michelle Feldman ◽  
Adam Widman ◽  
...  

The production of melanin increases skin pigmentation and reduces the risk of skin cancer. Melanin production depends on the pH of melanosomes, which are more acidic in lighter-skinned than in darker-skinned people. We showed that inhibition of soluble adenylyl cyclase (sAC) controlled pigmentation by increasing the pH of melanosomes both in cells and in vivo. Distinct from the canonical melanocortin 1 receptor (MC1R)–dependent cAMP pathway that controls pigmentation by altering gene expression, we found that inhibition of sAC increased pigmentation by increasing the activity of tyrosinase, the rate-limiting enzyme in melanin synthesis, which is more active at basic pH. We demonstrated that the effect of sAC activity on pH and melanin production in human melanocytes depended on the skin color of the donor. Last, we identified sAC inhibitors as a new class of drugs that increase melanosome pH and pigmentation in vivo, suggesting that pharmacologic inhibition of this pathway may affect skin cancer risk or pigmentation conditions.


1966 ◽  
Vol 123 (3) ◽  
pp. 351-352 ◽  
Author(s):  
B. A. GIBBARD ◽  
H. E. LEHMANN

2012 ◽  
Vol 187 (4S) ◽  
Author(s):  
Enrico Finazzi Agro ◽  
Pierluigi Bove ◽  
Claudio Perugia ◽  
Giuseppe Vespasiani ◽  
Annalisa Maugliani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document